Also, KIF5A protein expression levels correlated inversely with the levels of APP and soluble Aβ in AD brains, indicating that these effects may be an adaptive response to impaired axonal transport in AD (Hares et al., 2017). This evidence concerns the gene KIF5A and Alzheimer disease.